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Recognizing the diagnostic challenges that clinicians face when attempting to arrive at an 
accurate psychiatric diagnosis for individuals with intellectual/developmental disability (IDD) 
co-occurring with mental illness (MI), in 2007 the National Association for the Dually 
Diagnosed (NADD), in association with the American Psychiatric Association (APA), published 
Diagnostic Manual – Intellectual Disability (DM-ID): A Textbook of Diagnosis of Mental 
Disorders in Persons with Intellectual Disability (Fletcher, Loschen, Stavrakaki, & First, 2007).  
The DM-ID- was designed as a companion to the DSM-IV-TR and aimed to assist clinicians to 
arrive at a more accurate DSM-IV-TR diagnosis for individuals with IDD.  In 2013, the American 
Psychiatric Association published the DSM-5, thus necessitating revision of the DM-ID to 
incorporate the changes from the DSM-IV-TR to the DSM-5.  
The authors discuss the need for and development of the original DM-ID and changes in 
the DSM-5.  The authors then offer insight into several chapters in the DM-ID-2 across the 
lifespan of individuals with IDD, looking at the changes in the DSM-5 and how these impact the 




The Need for and Development of the DM-ID 
Individuals with IDD can experience the same psychiatric disorders as people in the 
general population.  While estimates of the prevalence of mental disorders among people with 
IDD varies, research indicates that the prevalence is higher with people who have IDD than in 
the general population.  Prevalence estimates range from 30% to 70% of individuals with IDD 
having mental illness or behavioral problems (Szymanski & King, 1999).  The range of findings 
can be attributed to a variety of factors including differences in population sampling and 
methodologies used in identifying psychiatric disorders in persons with IDD.  Two of the larger 
studies are: Cooper, Smiley, Morrison, Williamson, and Allan (2007) who revealed a rate of 
40.9% with a population-based study (N=1023) employing a comprehensive individualized 
clinical assessment; and National Core Indicators (NCI) which has identified a rate of 55% 
(N=13,466) (National Core Indicates, 2016) based on patient charts from thirty states in the U.S. 
Recognizing the diagnostic challenges that clinicians are faced with when attempting to 
arrive at an accurate diagnosis for individuals with intellectual/developmental disability (IDD) 
co-existing with mental illness (MI), the National Association for the Dually Diagnosed 
(NADD), in association with the American Psychiatric Association (APA), published Diagnostic 
Manual – Intellectual Disability (DM-ID): A Textbook of Diagnosis of Mental Disorders in 
Persons with Intellectual Disability in 2007 (Fletcher, Loschen, Stavrakaki, & First, 2007).  The 
challenges stem, to a great extent, from the difficulty or inability of individuals with IDD to 
describe their own symptoms.  Diagnosis for an individual within the population without IDD 
generally relies upon the person’s description of his or her experiences and feelings.  Individuals 
with IDD have limited receptive and expressive language, thus limiting their ability to describe 
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their symptoms.  They may also lack the self-reflection to describe internal states.  Furthermore, 
individuals with IDD who are experiencing mental illness may present in very different ways 
than their peers without IDD.  Accurate diagnosis can be further stymied by diagnostic 
overshadowing, in which the diagnosis of IDD can overshadow coexisting mental disorders and 
predispose practitioners to overlook the presence of psychopathology or attribute the symptoms 
of psychopathology to the IDD (Reiss, Levitan, & Szysko, 1982).  Also, some people with IDD 
tend to try to hide their disability under a “cloak of competence” while others may try to please 
the evaluator by providing the answer the individual thinks the evaluator wants (“acquiescence 
bias”). The DM-ID provides guidance for assessing and diagnosing specific disorders in 
individuals with IDD and provides information on recognizing challenging behaviors of 
individuals with IDD and how to differentiate between behavioral problems and psychiatric 
disorders.  The DM-ID was designed as a companion to the DSM-IV-TR and aimed to assist 
clinicians to arrive at a more accurate DSM-IV-TR diagnosis for individuals with IDD.   
Work on the DM-ID began almost ten years before its publication, when Dr. Robert 
Fletcher, Founder and CEO of NADD, submitted a proposal to the NADD Board of Directors to 
develop a companion to the DSM-IV to facilitate a more accurate DSM-IV diagnosis for people 
with IDD.  Experts were recruited for work groups for each diagnostic category.  Approximately 
60 experts participated in this project.  The editors for the DM-ID were Robert Fletcher, Earl 
Loschen, Chrissoula Stavrakaki, and Michael First.  The DM-ID covers all major diagnostic 
categories of mental disorders as defined in the DSM-IV-TR.  Each work group reviewed the 
existing research concerning the disorder(s) on which they were working, with emphasis on how 
the disorder manifests in individuals who have IDD.  The Cochrane system was used to evaluate 
the research reviewed (Cochrane Library, 2001).  Based upon the research and the work group’s 
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expert consensus, modifications and adaptations of the DSM-IV-TR diagnostic criteria were 
proposed which included addition of symptom equivalents, omission of symptoms, changes in 
symptom count, modification of symptom duration, modification of age requirements, addition 
of explanatory notes, and criteria sets that do not apply.  In addition, advice about working with 
the individual and with respondents in order to achieve an accurate diagnosis was provided.   
During the summer of 2006, prior to publication, field trials were held to assess the 
clinical usefulness of the DM-ID.  The results were reported briefly in the introduction to the 
DM-ID and more thoroughly in an article published in the Journal of Clinical Psychiatry in 2009 
(Fletcher et al., 2009).  Sixty three clinicians, from eleven different countries, were recruited to 
participate in the research.  These clinicians were asked to use the DM-ID with a minimum of 20 
clients and to provide feedback about the clinical usefulness of the DM-ID.  A clinical survey 
was developed.  Part I, completed once by each clinician, provided information about the 
training and experience of each clinician who participated in the field trials and sought the 
clinician’s assessment of the usefulness of the DSM-IV-TR when used with individuals who have 
IDD, as well as the clinician’s reasons for this assessment.  Part II was completed for each 
patient after the clinician had used the DM-ID to arrive at a diagnosis.  Demographic information 
about the client was collected, followed by information about the DSM-IV-TR diagnosis and the 
DM-ID diagnosis arrived at.  Finally, three yes/no questions about use of the DM-ID were 
answered: (1) “Did the DM-ID allow you to come up with a more specific diagnosis than you 
would have with DSM-IV-TR?” (2) “Did the DM-ID allow you to arrive at a psychiatric 
diagnosis that you think is appropriate for this patient?” and (3) “Did you find the DM-ID 
allowed you to avoid using the NOS (not otherwise specified) category” and three questions on a 
five point scale: (1) “Was the DM-ID easy to use (user-friendly) to arrive at a psychiatric 
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diagnosis for this patient?” (2) “Did you find the DM-ID clinically useful in the diagnosis of this 
patient?” and (3) “For the diagnosis used for this patient, do you feel that the number of adapted 
criteria were too few/excessive?” 
Eight hundred and forty five surveys on use of the DM-ID with specific patients were 
completed.  Overall, response to the use of the DM-ID was positive, with 67.9% of respondents 
rating the DM-ID as “easy” or “very easy” to use and 83.1% of respondents indicating that the 
DM-ID allowed them to arrive at an appropriate psychiatric diagnosis for the patient.  36.5% of 
clinicians indicated that the DM-ID allowed them to arrive at a more specific diagnosis than the 
DSM-IV-TR. 
The publication of the DSM-5 (American Psychiatric Association, 2013) necessitated that 
the DM-ID be updated.  NADD began putting together work groups to revise the DM-ID during 
the summer of 2012.  The editors of the revised DM-ID are Robert Fletcher, Jarrett Barnhill, and 
Sally Ann Cooper.  One hundred and four experts were recruited to work in 26 work groups.  A 
chairperson was identified for each work group.  Work has been proceeding on the various 
chapters, and publication is anticipated for the summer of 2016.  
Changes from DSM-IV to DSM-5 reflect developments in genetic research and 
neuroimaging as well as efforts to promote ease of use.  The disorders included in DSM-5 have 
been reordered into a revised organizational structure, reflecting the fact that mental disorders do 
not always fit completely within the boundaries of a single disorder and that some symptom 
domains involve multiple diagnostic categories.  DSM-5 recognizes developmental issues 
utilizing a lifespan approach and including descriptions of how the disorder presentation changes 
across the lifespan.  The multi-axial approach has been dropped.  A number of disorders that had 
been distinct in DSM-IV – such as autistic disorder, Asperger’s disorder, and pervasive 
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developmental disorder, have been consolidated in DSM-5 and the DM-ID-2 into autism 
spectrum disorder.  Trauma and stressor-related disorders in the DSM-5 and DM-ID-2 is an 
umbrella diagnostic area that now includes reactive attachment disorder, disinhibited social 
engagement disorder, and post traumatic stress disorder, acute stress disorder, and adjustment 
disorder. Disorders previously referred to as “dementias” are now designated as major or mild 
neurocognitive disorders.   
It would be impossible, in the space of this article, to review all the challenges faced in 
developing the DM-ID-2.  In the next sections, we will look at a sample of disorders discussed in 
the DSM-5 and the DM-ID-2, beginning with those often seen early in life (designated as 
neurodevelopmental disorders in the DSM-5) and ending with challenges encountered late in life 
(neurocognitive disorders).  In between these early lifetime and late lifetime challenges, we 
consider a group of disorders that have a serious impact on the lives of individuals with IDD: 
trauma and stressor related disorders.  The specific disorders found in this article are intended to 
illustrate issues of diagnostic limitations, lack of research in the population with IDD, and 
important changes in the conceptualization of these disorders.  
Neurodevelopmental Disorders 
The DSM-5 reconfigures “Disorders with Onset during Childhood and Adolescence” 
(found in DSM-IV-TR and DM-ID) and stereotypic movement disorders and tic disorders to 
create neurodevelopmental disorders. Neurodevelopmental disorders share three basic features- 
an age of onset during the developmental period, diverse etiologies, and a large number of 
overlapping symptoms that co-occur in what appear to be discrete syndromes.  But intellectual 
disability (intellectual developmental disorder) or IDD is included as a discrete “syndrome” 
within neurodevelopmental disorders. Herein lies a problem: IDD is a subset of 
neurodevelopmental disorders, yet it is frequently listed among the exclusion criteria in the 
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DSM-5 (American Psychiatric Association, 2013). The central focus of the DM-ID-2 is on co-
occurring IDD and mental disorders.  The presence of IDD shapes the presentation and course of 
many neurodevelopmental disorders and by doing so creates several cognitive dissonances.  In 
many circumstances, the clinicians will have to judge how to modify inclusion, specifiers, and 
exclusion criteria to match up with heterogeneous populations of individuals with IDD. 
Resolving these dissonances is one of the major challenges for the authors of this section.    
There are several additional changes in diagnostic criteria contained in both the DSM-5 
and the upcoming DM-ID-2 beyond those mentioned earlier such as the removal of the exclusion 
of ADHD in the context of ASD; the realigning of impulse control and disruptive behavior 
disorders; the creation of disruptive mood dysregulation disorder (DMD) for individuals with 
affect dysregulation and ADHD (previously diagnosed as bipolar disorder), and the creation of 
trauma and stress-related disorders (American Psychiatric Association, 2013).  
The DSM-5 modifies the diagnostic criteria for IDD in a manner that shifts the emphasis 
from IQ scores to social support needs. Severity of ID now depends upon the level of social 
supports needs as measured by functional domain criteria (conceptual, social, and practical 
domains). Yet even this shift towards an emphasis on adaptive criteria does not resolve the 
problems we face in capturing the multi-directional relationships between ID, other 
neurodevelopmental disorders and late onset psychiatric disorders. The presence of autism 
spectrum disorder (ASD) further complicates this process.   
 
Remaining Foundational Issues for People with IDD.  
1. Age of Onset – This is a more complex issue than it first seems. For many people with 
IDD, the presence of specific neurodevelopmental disorders can be “overshadowed” by 
baseline global cognitive and adaptive deficits. In addition, the majority of referrals for 
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individuals with IDD involve behavioral/psychiatric complaints rather than 
neurodevelopmental disorders. As a consequence, the various combinations of IDD, 
challenging behavior, and late onset psychiatric disorders can overshadow the “age” of 
onset for many neurodevelopmental disorders. It may be more useful to describe the age 
of recognition along with patterns of comorbidity in order to avoid the ambiguity 
associated with the determination of an age of onset (Barnhill, 2014).  
2. Parameters of the Developmental Period – Most mental health consultations and 
diagnoses are “point in time” events. As a result, the clinician has little opportunity to 
follow the ongoing development, especially the interactions between the person’s special 
vulnerabilities (including neurodevelopmental disorders), levels of resilience, and 
experiences across the life cycle. For example, the expression of many 
neurodevelopmental disorders changes in response to many interrelationships with IDD 
and ASD. These intertwining developmental trajectories influence and are influenced by 
the social ecology, changing academic or occupational demands; availability of learning 
experiences; impact of accessibility/utilization of services; and the vicissitudes of 
interventions for co-occurring mental disorders (Gardner, Griffiths & Hamlin, 2012). 
Each of these impact brain neuroplasticity secondary to new learning that blurs the 
endpoint of the neurodevelopmental period. From this perspective, most diagnoses are 
hypotheses that may change over time (Barnhill, 2011; Piek, Dawson, Smith, Gasson, 
2008).   
3. Diagnosis and Discrepancy Criteria- The concept of diagnosis relies upon measuring the 
gap between expected and actual performance is larger than that “normally associated 
with ID.” In many neurodevelopmental disorders, the diagnosis is either based on 
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standardized assessment scores or a judgement call by the clinician. Clinical judgement 
can be both a blessing and a curse. For example, the presence of IDD changes its 
developmental trajectory as well as the risk for co-occurring mental disorders. As a 
result, many standardized measures are not sufficiently normed. Test scores and clinical 
judgements can be undermined by the severity of ID; comorbidity with ASD or 
genetic/metabolic disorders; and heterogeneity found in many cognitive, social 
communication, attentional, executive functional and motor skills (Barnhill, 2003; 
Fletcher, Loeschen, Stavrakaki & First, 2007).  
4. Behavioral phenotypes and neurodegenerative disorders – Diagnosis is only as good as 
the quality of observation data and current scientific evidence. This evidence changes in 
response to new technologies, genetic discoveries (behavioral phenotypes or metabolic 
disorder), and the development of new treatments for evolving brain disorders. Recent 
evidence suggests that many late onset psychiatric disorders are preceded by 
unrecognized neurodevelopmental disorders (Barnhill, 2012). Genome-wide array studies 
(GWAS) suggest that ID, ASD, specific learning and attention deficit-hyperactivity 
disorders, and some forms of epilepsy share genetic profiles (Guilmarte et al., 2009). 
Early recognition and diagnosis of at risk infants and children permit early intervention of 
many neurodevelopmental and neurodegenerative disorders (Gresham & Vellutino, 
2010). Longitudinal assessment is useful in tracking the changing developmental 
trajectory as well as monitoring the efficacy of treatment intervention.  
 
Diagnostic Issues Needing More Study – The DM-ID-2 and Beyond 
Neurodevelopmental disorders appear as distinct syndromes that are largely based on 
phenomenology and not neurobiological criteria. Each syndrome represents a variety of complex 
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signs and symptoms that frequently co-occur with other neurodevelopmental, behavioral, and 
primary psychiatric disorders. For example, motor disorders are divided into three heterogeneous 
disorders; developmental co-ordination; stereotypic movement (with and without self-injury) and 
tic disorders. Each can be comorbid with attention deficit hyperactivity, specific learning, 
communication, or autism spectrum, intellectual disability, and obsessive-compulsive and related 
disorders (Barnhill, 2011). When SPID or ASD/SPID are present, these boundaries are likely 
more diffuse.  We are left to choose between making inappropriate diagnoses, excluding this 
population (nihilistic), or providing our best clinical judgement. Barnhill (2003, 2011) proposed 
an alternative, a pattern of DSM-IV-TR diagnosis that focused on defining neurobiological 
endophenotypes based on observable clusters of behaviors, patterns of comorbidity, trauma 
history (Aupperle, Melrose, Stein, & Paulus, 2012), and issues related to attachment 
temperament, and ethological features. In these articles the author algorithm resembles the 
Research Domain Criteria now considered to be an alternative to diagnostic classification 
systems for researchers (Adam, 2013).  
Unfortunately, many of our best practices and evidence-based medicine are based on 
lumping (large studies, statistical analyses, and meta-analyses) at the expense of defining specific 
endophenotypes or using data from single-case designed studies. Bridging the gaps between 
these conceptual models may provide useful insights that allow for more individualized 
treatment planning.          
 
Implications and Speculations  




The use of the functional domains to assign a level of severity for IDD make it reasonable 
device for classifying neurodevelopmental disorders in a similar manner. Currently discrepancy 
criteria include a domain for clinical judgement as well as the gap between actual and expected 
performance based on standardized instruments. Many of these instruments use age-based 
normative data that may have lessening degrees of validity and reliability for people with severe-
profound IDD. Perhaps the best examples are communication and specific learning disabilities 
(SLD). For nonverbal individuals with profound IDD the domains of comprehension, expression, 
and pragmatics need to be expanded. The global deficits associated with severe profound ID 
(SPID) limit the individual’s verbal and conceptual skills to the extent a more basic level of 
analysis that assesses functional neurobiological substrates such as the ability to use basic shape 
recognition, cued responses for previously learned skills or capacity to respond to picture 
communication systems. Even individuals with mild-moderate IDD may require modifications.  
Under these conditions, it may be more useful to augment test score with the pattern of scatter on 
the functional domains criteria (conceptual, social and practical) rather than 
discrepancy/performance criteria based on chronological or developmental age. This night add 
some structure to clinical judgment.  
The structure of the DSM-5 (symptoms, specifiers, exclusion criteria) can provide a 
methodology to differentiate primary and secondary neurodevelopmental disorders. Perhaps 
more useful is their application for creating diagnostic algorithms that can reduce the 
heterogeneity of neurodevelopmental disorders. For an example, the diagnosis for a person with 
chronic schizophrenia might read: chronic schizophrenia in the context of mild ID, behavioral 
phenotype associated with Velocardiofacial syndrome, history of childhood developmental co-
ordination and communication disorder (social pragmatics) and physical abuse during early 
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childhood. Such a diagnostic scheme can provide more useful information for monitoring 
symptoms change and implementing changes in treatment to match evolving clinical needs.  
Like the DSM-5, the DM-ID-2 is based on phenomenological rather than neuro-
biological subtypes. Although not included in the neurodevelopmental disorders, oppositional 
defiant and conduct disorders represent the convergence of biologically-based (e.g. relatedness to 
attention or impulse dys-control), socially “deviant” behaviors (callous unemotionality, 
irritability/overt defiance, violations of property or individual “rights”). For example, the 
relationship between ADHD, oppositional defiant and conduct disorders represent a subset of 
externalizing behavioral disorders that require a level of awareness for rule-governed social 
behaviors. They may also lie on a continuum of impulse dys-control, affective dysregulation, 
neuroticism and deficits in conceptual, social and practical skills. In this sense conduct and 
oppositional defiant disorders have limited utility for individuals with severe and profound ID. It 
may be more helpful to describe and address underlying temperamental, psychophysiological 
and behavioral response to threat or physical trauma, as well as genetic risk for ADHD or 
disruptive mood dysregulation disorder. The goal is to include more than a descriptive diagnosis 
and focusing instead on associated functional impairments.   
 
Trauma-and Stressor-Related Disorders 
Trauma-and stressor-related disorders include disorders in which exposure to a traumatic 
or stressful event is listed explicitly as a diagnostic criterion. This is a new chapter within DSM-
5 and includes reactive attachment disorder (RAD), disinhibited social engagement disorder 
(DSED), posttraumatic stress disorder (PTSD), acute stress disorder, and adjustment disorder. 
Within DM-ID these disorders were described in separate chapters, but in keeping with DSM-5 
they are brought together to reflect the increased understanding in the variation of expressing 
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psychological distress when an individual is exposed to a traumatic or stressful event. The 
inclusion of reactive attachment disorders and disinhibited social engagement disorder which 
develop early in life due to lack or absence of adequate caregiving show a recognition in the 
importance of early experiences on the later development of an individual including those with 
intellectual/developmental disability (IDD). 
Despite the frequency of pathogenic care and risk for neglect or abuse in people with 
IDD, it can be difficult to diagnose attachment disorders such as RAD and DSED in people with 
IDD.  This is due to a variety of reasons including biological and genetic factors that influence an 
individual’s ability to make attachments such as an autism spectrum disorder. In addition, there 
is a significant lack of research pertaining to both RAD and DSED in children and adults with 
IDD. There are instruments to assess the attachment behaviors of individuals with intellectual 
disabilities such as the Secure Base Safe Haven Observation List ( De Schipper & Schuegel, 
2010).  The need to screen individuals for difficulties in attachment behaviors within adult care 
settings is becomingly increasingly recognized (Schuengel, De Schipper, Sterkenburg, & Kaf, 
2013).  Adults and children with ID can show signs and symptoms of disordered attachment even 
with a secure attachment pattern (Minnis, Fleming, & Cooper, 2010).  Behaviors alone should 
not be used to diagnose RAD or DSED, but evidence of early life experiences of abuse, 
deprivation, and neglect should be sought. In individuals with borderline intellectual functioning 
or mild IDD referred for psychiatric consultation, the following prevalence figures have been 
reported with 42% exhibiting symptoms of overall disordered attachment, 16% showing 
symptoms of reactive attachment disorder, and 11% showing symptoms of both reactive 
attachment disorder and disinhibited social engagement disorder. Individuals in this study were 
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aged 5 to 11 and had borderline or mild IDD with IQs ranging between 50 and 85 and a mean IQ 
of 71.7 (Giltaji, Sterkenburg, & Schuengel, 2013). 
PTSD is a chronic disorder in response to trauma. With respect to ascertainment of PTSD 
in people with IDD, the research supports three important points: 1) people with IDD seem to be 
more vulnerable to the development of PTSD than members of the general population; 2) people 
with IDD are more often exposed to conditions known to contribute to the development of 
PTSD, such as interpersonal abuse and violence; and 3) for people with only mild IDD, the 
presentation of PTSD is similar to that seen in members of the general population (Wieland, 
Wardenaar, Dautovic, & Zitman, 2013). For people with more severe IDD, the presentation may 
be complicated by differing presentation of symptoms with a lower developmental functioning 
increasing the risk for developing PTSD (Mevissen & de Jongh, 2010). 
Acute stress disorder is characterized by symptoms similar to those of posttraumatic 
stress disorder that occurs immediately following exposure to one or more traumatic events. 
There is very little research on acute stress disorder presenting in those with IDD. Most of the 
evidence is from studies of PTSD with no reference to the first month of presentation in these 
studies when an acute stress disorder would be present.  
Adjustment disorders involve the development of clinically significant emotional or 
behavioral symptoms in response to an identifiable psychosocial stressor or stressors.  The 
stressor may be a single event or events or circumstances that are recurrent or continuous.  This 
definition incorporates an extremely valuable diagnostic concept, suggesting that environmental 
stressors, so common in the lives of persons with IDD, might be a critical source of 
psychopathology, which could otherwise be mistaken for other behavioral or mental health 
disorders.  As simply stated in the DSM-5, “When bad things happen, most people get 
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upset…the diagnosis should only be made when the magnitude of the distress…exceeds what 
would normally be expected…” Also noted in DSM-5 is the fact that what is normally expected 
may vary in different cultures, so clinicians serving people with IDD must take into 
consideration that the world of a person with IDD is a culture (e.g., residential setting) within a 
broader culture (geographic region, ethnic community, etc.).  In one study, Tsakanikos, Bouras, 
Costello & Holt (2007) looked at a clinic sample of people with IDD and demonstrated that IDD 
is associated with a general increase in psychological vulnerability to life events, with adjustment 
disorder being more likely for people with ID exposed to multiple events but not as closely 




DSM-5 replaced the term “dementias” with a characterization of these neurodegenerative 
disorders as neurocognitive disorders. Previously known as Dementia, Delirium, Amnestic, and 
Other Cognitive Disorders in DSM-IV-TR, these disorders comprise delirium, and major and 
mild neurocognitive disorder (NCD) in the DSM-5. The term “dementia” may still be used 
where physicians and patients are accustomed to this, but “neurocognitive disorder” is preferred, 
especially for conditions affecting younger adults. NCD is also seen as broader and encompasses 
disorders previously included under “Amnestic Disorders” in DSM-IV-TR. The 
conceptualization of delirium as a disturbance in consciousness (specifically in attention and 
awareness), which develops over a short period of time and is due to a direct physiological 




Major Neurocognitive Disorder (Major NCD) 
The DSM-5 has adopted a hierarchical approach to the diagnosis of NCDs, so that the 
criteria for major or mild NCD must be met before criteria for etiological subtypes such as 
Alzheimer’s disease (AD), Lewy body disease, or vascular disease can be applied. The essential 
feature of a major neurocognitive disorder is the development of multiple cognitive deficits that 
are severe enough to cause impairment in daily functioning and represents a decline from a 
previous level of functioning. To meet the diagnostic criteria for a major NCD, individuals must 
present with significant cognitive decline in one or more domains (including complex attention, 
executive function, learning and memory, language, perceptual-motor, or social cognition). The 
DSM-5 definition therefore differs from the DSM-IV and ICD-10 definitions which require an 
impairment in memory as well as at least one other cognitive disturbance; the rationale being to 
ensure that the diagnosis of an NCD would apply to most dementia etiological subtypes, whereas 
previous definitions were based on the typical presentation of AD and therefore less valid in 
other subtypes (Ganguli et al., 2011).  Most of what we know about the course of neurocognitive 
disorders in individuals with IDD comes from the study of individuals with Down syndrome 
(DS) and probable Alzheimer-type dementia. Although individuals with DS often present with 
memory decline, behavioral and other cognitive changes, such as deficits in executive 
functioning, are also prominent and may be the presenting symptoms in many cases (Strydom et 
al., 2010; Wiseman et al., 2015). As life expectancy of people with intellectual/developmental 
disabilities (ID) extends into older age, dementia is an increasing cause of morbidity and 
mortality. To update and summarize current knowledge on dementia in older adults with IDD, 
the authors conducted a comprehensive review of the published literature from 1997–2008 with a 
specific focus on: (1) epidemiology of dementia in IDD in general as well as in specific genetic 
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syndromes; (2) presentation; and (3) diagnostic criteria for dementia. The authors report that 
varied methodologies and inherent challenges in diagnosis yield a wide range of reported 
prevalence rates of dementia. Rates of dementia in the population with IDD without DS are 
comparable with or higher than the general population. Alzheimer's disease onset in DS appears 
earlier, and the prevalence increases from under 10% in the 40s to more than 30% in the 50s, 
with varying prevalence reported for those 60 and older. Incidence rates increase with age. Few 
studies of dementia in other genetic syndromes were identified. Presentation differs in the IDD 
population compared with the general population; Symptoms of depression, sleep disturbances, 
delusions, and auditory hallucinations may also be apparent when individuals with IDD develop 
dementia (Strydom et al., 2010), particularly in adults with DS (Dekker et al., 2015).  
Since the requirement for both memory and at least one other cognitive decline has been 
shown to affect the performance of dementia diagnoses in individuals with DS or IDD (Sheehan 
et al., 2014; Strydom et al., 2013), the new streamlined criteria for NCDs, therefore, have 
considerable face validity in this population. Nevertheless, several limitations in applying the 
criteria for NCD in individuals with IDD are apparent, the most important of which is the 
difficulty in objectively defining cognitive impairment and decline in a population with pre-
morbid deficits. Individuals may have a wide range of baseline abilities across different domains, 
and there is considerable between-individual variation. Criteria therefore need to clearly state 
that a change from an individual’s own baseline is required for a diagnosis of dementia; the new 
DSM-5 NCD criteria do indeed require significant decline from a previous level of performance. 
This must be based on concern from an individual, knowledgeable informant, or clinician, as 
well as documented by standardized neuropsychological testing, or in its absence, another 
qualified clinical assessment.  
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Formal neuropsychological testing is difficult due to the limited range of tests suitable for 
the population with ID, especially for those with more severe intellectual disability. It is also 
difficult to ‘optimize’ cognitive tests due to factors such as emotional states, sensory problems, 
and medical status. Questionnaire-based assessment of cognitive functioning reported by 
caregivers are often used instead, though these may not map well on to specific cognitive 
domains and the ‘context’ may not be considered, e.g. whether a task is regularly ignored 
because the person is unwilling to do it rather than unable to do it. Reliability of informant 
reports of impairment or decline may also be an issue, particularly when information is obtained 
from different caregivers at different times. However, retrospective report has been found to be 
as good as prospective ratings (Jamieson-Craig,, Scior, Chan, Fenton, & Strydom, 2010) and an 
adjustment to the DSM-5 major NCD criterion for neuropsychological testing may therefore be 
to use informant-based questionnaires to demonstrate decline , such as e.g. the Dementia 
Questionnaire for Persons with Mental Retardation – DMR; (Evenhuis, 1996) or the CAMDEX-
DS (Ball, Holland, Huppert, Trepper, & Dodd, 2016).   
Mild Neurocognitive Disorder  
DSM-5 introduced the term “mild neurocognitive disorder” to refer to a pre-clinical state 
of having symptoms akin to dementia which precedes significant functional impairment. Mild 
NCD can be distinguished from major NCD by the severity of the cognitive decline (modest vs. 
significant) and the impact the symptoms have on everyday function; for a diagnosis of mild 
NCD the cognitive deficits do not interfere with capacity for independence in everyday activities.  
However, in individuals with IDD this may be difficult to apply, given their variable premorbid 
abilities and lifelong dependence on support. Indeed, a similar definition of mild cognitive 
impairment has been found to have poor predictive validity in individuals with IDD (Strydom et 
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al., 2013) and could result in over-diagnosis. However, this diagnosis may be useful in 
individuals at high risk for dementia such as those with DS, particularly in research settings, and 
could help to diagnose dementia at an earlier stage as long as the individual’s own baseline is 




 The authors in this article have first explored the evolution of the DSM to the DM-ID 
nosology systems.  Then a discussion about neurodevelopmental disorders follows.  These 
disorders share three basic features – an age of onset during the developmental period, diverse 
etiologies, and a large number of overlapping symptoms that co-occur in what appear to be 
discrete syndromes.  Clinicians will have to judge how best to modify inclusion, specifiers, and 
exclusion criteria to apply these diagnostic criteria to individuals with IDD.  The authors address 
trauma and stressor-related disorders which include disorders in which exposure to a traumatic or 
stressful event is listed explicitly as a diagnostic criterion.  Most of the recent research around 
trauma & stressor-related disorders has focused on PTSD and there remains a need for further 
research to look at the impact of the early experiences of trauma on the attachment behaviors of 
people with IDD. The benefits of DM-ID 2 will be to support how we recognize these disorders 
from a clinical perspective but also be a basis to support further research of these disorders in 
persons with IDD.  Finally, the authors point out clinical issues as they pertain to neurocognitive 
disorders and their relationship to IDD.  The DSM-5 and the DM-ID-2 include criteria for major 
neurocognitive disorder and mild neurocognitive disorder.  While the criteria for major 
neurocognitive disorder have several characteristics which will help to diagnose dementia in 
individuals with ID, the validity of mild neurocognitive disorder should be established before it 
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